glp 1 in germany Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products The trillion-dollar GLP-1 fiscal opportunity

Patients with type 2 diabetes who are prescribed liraglutide have a 179% higher likelihood of developing non-arteritic anterior ischemic optic neuropathy (NAION), while those prescribed insulin have an 86% greater likelihood compared to patients who were prescribed other diabetes medications

Patients typically experience a 15-20% reduction in weight.

Which means the true safety signal may be larger than we see

See my before and after picture after using Semaglutide through Try Eden, a GLP-1 weight loss service that I tried.

| Walgreens is wading into the self-pay GLP-1 space, going head-to-head with telehealth subscription offerings.